194 related articles for article (PubMed ID: 18238941)
1. Effects of a heat shock protein inducer on the atrial fibrillation substrate caused by acute atrial ischaemia.
Sakabe M; Shiroshita-Takeshita A; Maguy A; Brundel BJ; Fujiki A; Inoue H; Nattel S
Cardiovasc Res; 2008 Apr; 78(1):63-70. PubMed ID: 18238941
[TBL] [Abstract][Full Text] [Related]
2. Induction of heat shock response protects the heart against atrial fibrillation.
Brundel BJ; Shiroshita-Takeshita A; Qi X; Yeh YH; Chartier D; van Gelder IC; Henning RH; Kampinga HH; Nattel S
Circ Res; 2006 Dec; 99(12):1394-402. PubMed ID: 17110598
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein inducer modifies arrhythmogenic substrate and inhibits atrial fibrillation in the failing heart.
Chang SL; Chen YC; Hsu CP; Kao YH; Lin YK; Lai YJ; Yeh HI; Higa S; Chen SA; Chen YJ
Int J Cardiol; 2013 Oct; 168(4):4019-26. PubMed ID: 23871620
[TBL] [Abstract][Full Text] [Related]
4. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S
Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation.
Brundel BJ; Henning RH; Ke L; van Gelder IC; Crijns HJ; Kampinga HH
J Mol Cell Cardiol; 2006 Sep; 41(3):555-62. PubMed ID: 16876820
[TBL] [Abstract][Full Text] [Related]
6. Induction of heat shock proteins prevents the arrhythmogenic substrate for atrial fibrillation.
Takahashi N; Wakisaka O; Yoshimatsu H; Saikawa T
Int J Hyperthermia; 2009 Dec; 25(8):641-6. PubMed ID: 19680998
[TBL] [Abstract][Full Text] [Related]
7. The pharmacological response of ischemia-related atrial fibrillation in dogs: evidence for substrate-specific efficacy.
Rivard L; Sinno H; Shiroshita-Takeshita A; Schram G; Leung TK; Nattel S
Cardiovasc Res; 2007 Apr; 74(1):104-13. PubMed ID: 17316585
[TBL] [Abstract][Full Text] [Related]
8. Oral geranylgeranylacetone treatment increases heat shock protein expression in human atrial tissue.
van Marion DMS; Dorsch L; Hoogstra-Berends F; Kakuchaya T; Bockeria L; de Groot NMS; Brundel BJJM
Heart Rhythm; 2020 Jan; 17(1):115-122. PubMed ID: 31302249
[TBL] [Abstract][Full Text] [Related]
9. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of small-conductance Ca2+-activated K+ channels terminates and protects against atrial fibrillation.
Diness JG; Sørensen US; Nissen JD; Al-Shahib B; Jespersen T; Grunnet M; Hansen RS
Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):380-90. PubMed ID: 20562443
[TBL] [Abstract][Full Text] [Related]
11. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.
Burstein B; Comtois P; Michael G; Nishida K; Villeneuve L; Yeh YH; Nattel S
Circ Res; 2009 Dec; 105(12):1213-22. PubMed ID: 19875729
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic gap junction conduction-enhancing antiarrhythmic peptide GAP-134 administration on experimental atrial fibrillation in dogs.
Laurent G; Leong-Poi H; Mangat I; Moe GW; Hu X; So PP; Tarulli E; Ramadeen A; Rossman EI; Hennan JK; Dorian P
Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):171-8. PubMed ID: 19808462
[TBL] [Abstract][Full Text] [Related]
13. Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction.
Sakabe M; Fujiki A; Sakamoto T; Nakatani Y; Mizumaki K; Inoue H
J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1130-5. PubMed ID: 22587612
[TBL] [Abstract][Full Text] [Related]
14. Geranylgeranylacetone, a noninvasive heat shock protein inducer, induces protein kinase C and leads to neuroprotection against cerebral infarction in rats.
Uchida S; Fujiki M; Nagai Y; Abe T; Kobayashi H
Neurosci Lett; 2006 Apr; 396(3):220-4. PubMed ID: 16406313
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein inducer GGA*-59 reverses contractile and structural remodeling via restoration of the microtubule network in experimental Atrial Fibrillation.
Hu X; Li J; van Marion DMS; Zhang D; Brundel BJJM
J Mol Cell Cardiol; 2019 Sep; 134():86-97. PubMed ID: 31302117
[TBL] [Abstract][Full Text] [Related]
16. The protective effect of heat shock protein 70 (Hsp70) in atrial fibrillation in various cardiomyopathy conditions.
Min TJ; Jo WM; Shin SY; Lim HE
Heart Vessels; 2015 May; 30(3):379-85. PubMed ID: 24890362
[TBL] [Abstract][Full Text] [Related]
17. Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart.
Ooie T; Takahashi N; Saikawa T; Nawata T; Arikawa M; Yamanaka K; Hara M; Shimada T; Sakata T
Circulation; 2001 Oct; 104(15):1837-43. PubMed ID: 11591623
[TBL] [Abstract][Full Text] [Related]
18. Atrial ischemia promotes atrial fibrillation in dogs.
Sinno H; Derakhchan K; Libersan D; Merhi Y; Leung TK; Nattel S
Circulation; 2003 Apr; 107(14):1930-6. PubMed ID: 12668526
[TBL] [Abstract][Full Text] [Related]
19. Screening of novel HSP-inducing compounds to conserve cardiomyocyte function in experimental atrial fibrillation.
van Marion DM; Hu X; Zhang D; Hoogstra-Berends F; Seerden JG; Loen L; Heeres A; Steen H; Henning RH; Brundel BJ
Drug Des Devel Ther; 2019; 13():345-364. PubMed ID: 30705583
[TBL] [Abstract][Full Text] [Related]
20. Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model.
Ishii Y; Kwong JM; Caprioli J
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1982-92. PubMed ID: 12714633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
